Challenges for the FDA : the Future of Drug Safety : Workshop Summary /

Saved in:

Bibliographic Details
Online Access:	Full text (MCPHS users only)
Corporate Authors:	Symposium on the Future of Drug Safety: Challenges for the FDA Washington, D.C., Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation
Other Authors:	Pray, Leslie A., Robinson, Sally
Format:	Electronic Conference Proceeding eBook
Language:	English
Published:	Washington, DC : National Academies Press, 2007
Series:	Online access: NCBI NCBI Bookshelf.
Subjects:	United States. > Food and Drug Administration > Rules and practice. United States > Food and Drug Administration > rules & practice United States > Food and Drug Administration Drugs > United States > Testing > Congresses. Drugs > United States > Safety measures > Congresses. Drugs > Side effects. Pharmacovigilance. Drugs > Side effects > Reporting. Drug monitoring. Drug interactions. Drug-Related Side Effects and Adverse Reactions > prevention & control United States Food and Drug Administration Drug Approval > organization & administration Drug-Related Side Effects and Adverse Reactions Drug Approval Safety Pharmacovigilance Drug Monitoring Drug Combinations Product Surveillance, Postmarketing Product Surveillance, Postmarketing > standards Adverse Drug Reaction Reporting Systems > organization & administration Drug Evaluation, Preclinical > standards Drug Interactions Government Agencies United States Congress Rules and practice proceedings (reports) Conference papers and proceedings.
Local Note:	ProQuest Ebook Central

MARC


LEADER	00000cam a2200000 a 4500
001	in00000287855
006	m o d
007	cr cn\|\|\|\|\|\|\|\|\|
008	071102s2007 dcua ob 100 0 eng d
005	20240703150736.6
016	7		\|a 101322122 \|2 DNLM
019			\|a 181376398 \|a 183443328 \|a 475453663 \|a 475741928 \|a 567853852 \|a 647678150 \|a 722611096 \|a 728031959 \|a 815538265 \|a 923277608 \|a 961523953 \|a 962624501 \|a 966145583 \|a 971082223 \|a 988418322 \|a 990522669 \|a 992071254 \|a 1021269247 \|a 1028789484 \|a 1037420817 \|a 1037921538 \|a 1038601714 \|a 1045566758 \|a 1047527090 \|a 1048091038 \|a 1055333940 \|a 1061050204 \|a 1061072841 \|a 1062859138 \|a 1083609556 \|a 1109214043 \|a 1113544863 \|a 1119444134 \|a 1119454998 \|a 1119510321 \|a 1120878956 \|a 1125481363 \|a 1136207719 \|a 1144245563 \|a 1153533700 \|a 1156336231 \|a 1159633323 \|a 1200860956 \|a 1204377088 \|a 1204381285 \|a 1227634114 \|a 1228592672 \|a 1229309366 \|a 1290068585 \|a 1300630567 \|a 1303369010 \|a 1303422458 \|a 1306559438 \|a 1398003563
020			\|a 9780309109871 \|q (electronic bk.)
020			\|a 0309109876 \|q (electronic bk.)
020			\|a 1281093556
020			\|a 9781281093554
020			\|a 9786611093556
020			\|a 6611093559
020			\|a 0309179440
020			\|a 9780309179447
020			\|z 0309109868
020			\|z 9780309109864
029	1		\|a AU@ \|b 000044592272
029	1		\|a AU@ \|b 000051467432
029	1		\|a DEBBG \|b BV043099275
029	1		\|a DEBBG \|b BV044108742
029	1		\|a DEBSZ \|b 422170380
029	1		\|a GBVCP \|b 802733832
029	1		\|a NZ1 \|b 14238379
035			\|a (OCoLC)290490622 \|z (OCoLC)181376398 \|z (OCoLC)183443328 \|z (OCoLC)475453663 \|z (OCoLC)475741928 \|z (OCoLC)567853852 \|z (OCoLC)647678150 \|z (OCoLC)722611096 \|z (OCoLC)728031959 \|z (OCoLC)815538265 \|z (OCoLC)923277608 \|z (OCoLC)961523953 \|z (OCoLC)962624501 \|z (OCoLC)966145583 \|z (OCoLC)971082223 \|z (OCoLC)988418322 \|z (OCoLC)990522669 \|z (OCoLC)992071254 \|z (OCoLC)1021269247 \|z (OCoLC)1028789484 \|z (OCoLC)1037420817 \|z (OCoLC)1037921538 \|z (OCoLC)1038601714 \|z (OCoLC)1045566758 \|z (OCoLC)1047527090 \|z (OCoLC)1048091038 \|z (OCoLC)1055333940 \|z (OCoLC)1061050204 \|z (OCoLC)1061072841 \|z (OCoLC)1062859138 \|z (OCoLC)1083609556 \|z (OCoLC)1109214043 \|z (OCoLC)1113544863 \|z (OCoLC)1119444134 \|z (OCoLC)1119454998 \|z (OCoLC)1119510321 \|z (OCoLC)1120878956 \|z (OCoLC)1125481363 \|z (OCoLC)1136207719 \|z (OCoLC)1144245563 \|z (OCoLC)1153533700 \|z (OCoLC)1156336231 \|z (OCoLC)1159633323 \|z (OCoLC)1200860956 \|z (OCoLC)1204377088 \|z (OCoLC)1204381285 \|z (OCoLC)1227634114 \|z (OCoLC)1228592672 \|z (OCoLC)1229309366 \|z (OCoLC)1290068585 \|z (OCoLC)1300630567 \|z (OCoLC)1303369010 \|z (OCoLC)1303422458 \|z (OCoLC)1306559438 \|z (OCoLC)1398003563
035			\|a (OCoLC)ocn290490622
040			\|a CaPaEBR \|b eng \|e pn \|c COCUF \|d OCLCQ \|d N$T \|d YDXCP \|d IDEBK \|d COF \|d OCLCQ \|d DKDLA \|d CCO \|d E7B \|d GPM \|d NNM \|d TFW \|d OCLCQ \|d FVL \|d OCLCQ \|d OCLCA \|d YBM \|d OCLCF \|d OCLCQ \|d NLGGC \|d OCLCO \|d OCLCA \|d MMU \|d ZCU \|d OCLCO \|d OCL \|d OCLCO \|d OCLCQ \|d OCLCO \|d EBLCP \|d OCLCO \|d OCLCQ \|d OCLCO \|d NKT \|d OCLCQ \|d OCLCO \|d AZK \|d OCLCO \|d LOA \|d OCLCA \|d VT2 \|d OCLCQ \|d TOA \|d OCLCO \|d AGLDB \|d CNNOR \|d OCLCO \|d MOR \|d LIP \|d PIFBR \|d OCLCQ \|d MERER \|d OCLCO \|d OCLCQ \|d MERUC \|d OCLCO \|d OCLCQ \|d NJR \|d OCLCO \|d U3W \|d CASUM \|d OCLCO \|d BUF \|d OCLCO \|d OCLCQ \|d CUY \|d KIJ \|d OCLCO \|d OCLCQ \|d BRL \|d OCLCO \|d STF \|d VNS \|d WRM \|d OCLCO \|d VTS \|d NRAMU \|d EZ9 \|d OCLCQ \|d ICG \|d OCLCO \|d AU@ \|d OCLCO \|d OCLCQ \|d S9I \|d WYU \|d G3B \|d TKN \|d OCLCO \|d A6Q \|d U3G \|d OCLCQ \|d DKC \|d OCLCQ \|d OCLCO \|d M8D \|d OCLCO \|d OCL \|d OCLCO \|d OCLCQ \|d OCLCO \|d HS0 \|d UKBTH \|d UKAHL \|d OCLCQ \|d K6U \|d OCLCA \|d UKCRE \|d LVT \|d OCLCO \|d SDF \|d TUHNV \|d UUM \|d DST \|d OCLCO \|d OCLCQ \|d OCL \|d TNZ \|d INARC \|d OCLCO \|d OCLCL
043			\|a n-us---
050		4	\|a RM301.27 \|b .S96 2007eb
060		4	\|a 2007 L-855
060		4	\|a QV 771 \|b S9889c 2007
072		7	\|a MED \|x 023000 \|2 bisacsh
072		7	\|a MED \|x 071000 \|2 bisacsh
072		7	\|a MED \|x 072000 \|2 bisacsh
072		7	\|a MED \|x 058170 \|2 bisacsh
072		7	\|a K \|2 bicssc
082	0	4	\|a 615/.19 \|2 22
111	2		\|a Symposium on the Future of Drug Safety: Challenges for the FDA \|d (2007 : \|c Washington, D.C.)
245	1	0	\|a Challenges for the FDA : \|b the Future of Drug Safety : Workshop Summary / \|c Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs.
260			\|a Washington, DC : \|b National Academies Press, \|c ©2007.
300			\|a 1 online resource (xvii, 109 pages) : \|b illustrations
336			\|a text \|b txt \|2 rdacontent
337			\|a computer \|b c \|2 rdamedia
338			\|a online resource \|b cr \|2 rdacarrier
347			\|a data file
504			\|a Includes bibliographical references (pages 78-79).
505	0		\|a Addressing the FDA's Resource Challenges -- Strengthening the Scientific Base of the Agency -- Integrating Pre- and Postmarket Review -- Enhancing Postmarket Safety Monitoring -- Conducting Confirmatory Drug Safety and Efficacy Studies -- Enhancing the Value of Clinical Trial Registration -- Enhancing Postmarket Regulation and Enforcement -- Looking to the Future.
546			\|a English.
588	0		\|a Print version record.
590			\|a ProQuest Ebook Central \|b Ebook Central College Complete
610	1	0	\|a United States. \|b Food and Drug Administration \|x Rules and practice.
610	1	2	\|a United States \|b Food and Drug Administration \|x rules & practice
610	1	2	\|a United States \|b Food and Drug Administration
650		0	\|a Drugs \|z United States \|x Testing \|v Congresses.
650		0	\|a Drugs \|z United States \|x Safety measures \|v Congresses.
650		0	\|a Drugs \|x Side effects.
650		0	\|a Pharmacovigilance.
650		0	\|a Drugs \|x Side effects \|x Reporting.
650		0	\|a Drug monitoring.
650		0	\|a Drug interactions.
650	1	2	\|a Drug-Related Side Effects and Adverse Reactions \|x prevention & control
650		2	\|a United States Food and Drug Administration
650	1	2	\|a Drug Approval \|x organization & administration
650	1	2	\|a Drug-Related Side Effects and Adverse Reactions
650	1	2	\|a Drug Approval
650	1	2	\|a Safety
650		2	\|a Pharmacovigilance
650		2	\|a Drug Monitoring
650		2	\|a Drug Combinations
650	2	2	\|a Product Surveillance, Postmarketing
650	2	2	\|a Product Surveillance, Postmarketing \|x standards
650	2	2	\|a Adverse Drug Reaction Reporting Systems \|x organization & administration
650	2	2	\|a Drug Evaluation, Preclinical \|x standards
650	2	2	\|a Drug Interactions
650	2	2	\|a Government Agencies
651		2	\|a United States
655		2	\|a Congress
655		2	\|a Rules and practice
655		7	\|a proceedings (reports) \|2 aat
655		7	\|a Conference papers and proceedings. \|2 lcgft
700	1		\|a Pray, Leslie A.
700	1		\|a Robinson, Sally.
710	2		\|a Institute of Medicine (U.S.). \|b Forum on Drug Discovery, Development, and Translation.
758			\|i has work: \|a Challenges for the FDA (Text) \|1 https://id.oclc.org/worldcat/entity/E39PCFYtGBHfXmjFMTdF7Qwf7b \|4 https://id.oclc.org/worldcat/ontology/hasWork
776	0	8	\|i Print version: \|a Symposium on the Future of Drug Safety: Challenges for the FDA (2007 : Washington, D.C.). \|t Challenges for the FDA. \|d Washington, DC : National Academies Press, ©2007 \|z 0309109868 \|z 9780309109864 \|w (OCoLC)180204137
830		0	\|a Online access: NCBI NCBI Bookshelf.
852			\|b E-Collections \|h ProQuest
856	4	0	\|u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=3378297 \|z Full text (MCPHS users only) \|t 0
936			\|a BATCHLOAD
938			\|a Askews and Holts Library Services \|b ASKH \|n AH36616777
938			\|a Askews and Holts Library Services \|b ASKH \|n AH36557992
938			\|a ProQuest Ebook Central \|b EBLB \|n EBL3378297
938			\|a ebrary \|b EBRY \|n ebr10197081
938			\|a EBSCOhost \|b EBSC \|n 209897
938			\|a ProQuest MyiLibrary Digital eBook Collection \|b IDEB \|n 109355
938			\|a YBP Library Services \|b YANK \|n 2745124
938			\|a Internet Archive \|b INAR \|n challengesforfda0000symp
947			\|a FLO \|x pq-ebc-base
999	f	f	\|s bab6e307-f245-4e52-9bee-7ec98c534a29 \|i 16f55f1f-e180-42fb-996d-33338e9e07db \|t 0
952	f	f	\|a Massachusetts College of Pharmacy and Health Sciences \|b Online \|c Online \|d E-Collections \|t 0 \|e ProQuest \|h Other scheme
856	4	0	\|t 0 \|u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=3378297 \|y Full text (MCPHS users only)

Challenges for the FDA : the Future of Drug Safety : Workshop Summary /

MARC

Similar Items